From 61f78f0a2230479ab024817dcbe87698416770a3 Mon Sep 17 00:00:00 2001 From: borja Date: Wed, 30 Oct 2024 15:01:19 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/InCORNTD 2025___Application.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/InCORNTD 2025___Application.md b/pages/InCORNTD 2025___Application.md index 6485cb58..dacab12e 100644 --- a/pages/InCORNTD 2025___Application.md +++ b/pages/InCORNTD 2025___Application.md @@ -1,6 +1,6 @@ # [[2024/10/30]] - **Título**: Fixed dose albenzadole/ivermectin coformulation, an innovative tool to help countries achieve their NTD control goals in a post-donation era - **Description**: The fixed-dose coformulation of albendazole and ivermectin is the result of 10+ years of innovations carried out by African and European organizations working through public-private partnerships. - This orodispersible, mango-flavoured tablet has already demonstrated safety and efficacy against soil-transmitted helminths in a pivotal trial and is currently + This orodispersible, mango-flavoured tablet has already demonstrated safety and efficacy against soil-transmitted helminths in a pivotal trial and is currently being evaluated by the European Medicines Agency under the EU-M4All procedure The fixed-dose combination of albendazole and ivermectin provides a novel approach to mass drug administration campaigns that simplifies logistics while providing better efficacy against more species of helminths. - \ No newline at end of file